Dr Duncan Veal, an experienced microbiologist, will step down as CEO and as a director to take over the role of chief technology officer. His key responsibility will be to drive the pipeline of new products to the market from the company’s manufacturing and R&D facility in Germany.
Fluorotechnics’ prime business focus since its inception in 2002 has been on product development. The successful commercialisation of these products sees the company’s emphasis now move strongly to sales and operations.
"The change in roles for James and Duncan is both timely and logical," said the chairman, Rick Taylor.
James Walker has been the company’s chief financial and operations officer since July 2002. James moved to Germany 9 months ago and has shown his operations skills in leading the scale up of our production facilities and fostering teamwork within our Germany subsidiary. Prior to joining Fluorotechnics, James was the CFO at the Hotel Dynamics Group and had been the CFO of another ASX listed biotechnology company.
"I am looking forward to leading Fluorotechnics through this exciting phase of converting customers to our leading edge products," said James Walker.
About Fluorotechnics: Fluorotechnics sells and develops innovative consumables and equipment that enable scientists to better measure biological processes using fluorescence.
The company has established itself as the global leader in the supply of products which are environmentally friendly, safe to use and offer a unique solution and superior performance compared to existing products. These products are used globally by our customers in research, quality control and diagnostics.
